0,868  0,003  Cholesterol antagonist
0,804  0,009  CYP3A4 substrate
0,788  0,004  NOS3 expression inhibitor
0,731  0,003  UGT1A4 substrate
0,735  0,010  CYP2C9 substrate
0,726  0,009  Respiratory analeptic
0,730  0,014  Teratogen
0,713  0,003  Prostatic (benign) hyperplasia treatment
0,690  0,004  Hair growth stimulant
0,686  0,016  Embryotoxic
0,652  0,010  CYP2C19 substrate
0,651  0,016  Alzheimer's disease treatment
0,648  0,013  Antihypercholesterolemic
0,637  0,004  Anesthetic
0,647  0,028  Antineoplastic (breast cancer)
0,602  0,003  UGT2B4 substrate
0,602  0,005  Muscle relaxant
0,608  0,024  TNF expression inhibitor
0,593  0,012  Hepatic disorders treatment
0,595  0,014  Analeptic
0,624  0,047  Antiinflammatory
0,620  0,045  Apoptosis agonist
0,586  0,014  CYP2D6 substrate
0,574  0,015  Antipruritic, allergic
0,551  0,005  Sulfotransferase substrate
0,564  0,018  Immunosuppressant
0,562  0,016  CTGF expression inhibitor
0,543  0,003  Prostate disorders treatment
0,521  0,005  Antiacne
0,517  0,007  Anesthetic general
0,512  0,005  Contraceptive
0,522  0,018  Proliferative diseases treatment
0,504  0,005  Abortion inducer
0,499  0,004  Autism spectrum disorders treatment
0,515  0,025  Bone diseases treatment
0,497  0,008  Interleukin 2 agonist
0,503  0,016  Antiprotozoal (Leishmania)
0,491  0,006  Cholinergic
0,490  0,012  Antineoplastic enhancer
0,508  0,031  Prostate cancer treatment
0,511  0,043  Transcription factor NF kappa B inhibitor
0,467  0,011  Interleukin agonist
0,460  0,005  Lipocortins synthesis antagonist
0,455  0,007  UGT2B7 substrate
0,472  0,024  Antiosteoporotic
0,451  0,007  Sodium/bile acid cotransporter inhibitor
0,452  0,015  UDP-glucuronosyltransferase substrate
0,452  0,019  Cardiodepressant
0,436  0,003  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,438  0,007  Skeletal muscle relaxant
0,436  0,005  Butyrylcholinesterase inhibitor
0,455  0,025  Metabolic disease treatment
0,428  0,009  Interferon gamma antagonist
0,423  0,006  Endometrios treatment
0,411  0,005  Psychosexual dysfunction treatment
0,409  0,003  Posttraumatic stress disorder treatment
0,435  0,031  Antiepileptic
0,405  0,004  Contraceptive male
0,402  0,004  Cholesterol synthesis inhibitor
0,415  0,021  Antineoplastic (liver cancer)
0,399  0,007  Acetylcholinesterase inhibitor
0,428  0,039  Antineoplastic (ovarian cancer)
0,430  0,042  Immunostimulant
0,419  0,034  Antineoplastic (pancreatic cancer)
0,395  0,014  Hepatoprotectant
0,382  0,011  Antialcoholic
0,403  0,039  AR expression inhibitor
0,447  0,085  Caspase 9 stimulant
0,372  0,013  Antipruritic, non-allergic
0,392  0,036  Chemoprotective
0,359  0,005  Hedgehog signaling inhibitor
0,410  0,058  CYP2C19 inhibitor
0,356  0,005  Contraceptive female
0,351  0,002  5-Alpha-reductase inhibitor
0,354  0,007  Antihyperlipoproteinemic
0,388  0,042  CYP1A2 substrate
0,378  0,045  Apoptosis antagonist
0,362  0,029  Psychostimulant
0,336  0,006  Androgen antagonist
0,356  0,030  Antineoplastic (endocrine cancer)
0,325  0,004  UGT2B10 substrate
0,361  0,041  Cytotoxic
0,353  0,034  Chemopreventive
0,346  0,032  Nitric oxide antagonist
0,355  0,042  Sensitization
0,360  0,057  ICAM1 expression inhibitor
0,305  0,002  Glycine receptor agonist
0,364  0,062  Mood disorders treatment
0,340  0,038  Amyotrophic lateral sclerosis treatment
0,339  0,041  Cardiovascular analeptic
0,301  0,011  DNA polymerase I inhibitor
0,291  0,002  RNA-directed RNA polymerase stimulant
0,362  0,082  Antiobesity
0,354  0,078  Antineoplastic (lung cancer)
0,332  0,059  Antineoplastic (melanoma)
0,285  0,014  Toxic, respiratory center
0,289  0,018  Antiviral (Influenza A)
0,300  0,036  Antiparkinsonian, rigidity relieving
0,263  0,004  Antineoplastic alkaloid
0,306  0,047  Vascular (periferal) disease treatment
0,315  0,062  Radioprotector
0,260  0,007  Menstruation disorders treatment
0,271  0,022  UGT2B15 substrate
0,302  0,055  Cardiotonic
0,306  0,059  UGT1A9 substrate
0,281  0,035  Antiviral (Influenza)
0,245  0,003  Glycine receptor antagonist
0,259  0,018  UGT2B9 substrate
0,267  0,032  Diabetic retinopathy treatment
0,253  0,020  Cholinergic antagonist
0,252  0,020  Anesthetic local
0,252  0,020  Acetylcholine antagonist
0,235  0,004  Cushing's syndrome treatment
0,270  0,040  UGT1A1 substrate
0,270  0,041  Sedative
0,236  0,009  Arachidonic acid antagonist
0,295  0,072  Spasmolytic
0,233  0,014  Farnesoid X receptor antagonist
0,243  0,025  LDLR expression enhancer
0,241  0,029  Muscular dystrophy treatment
0,269  0,060  Cytostatic
0,219  0,012  Antiinfertility, female
0,218  0,011  Antineoplastic, alkylator
0,210  0,004  Androgen agonist
0,288  0,083  Antidepressant
0,215  0,011  Acetylcholine nicotinic antagonist
0,259  0,058  UGT1A6 substrate
0,215  0,015  Anticataract
0,334  0,135  Antidiabetic
0,334  0,135  Cyclophilin D inhibitor
0,207  0,008  Aromatase inhibitor
0,202  0,004  UGT2B11 substrate
0,250  0,055  Carcinogenic
0,198  0,003  5-Alpha-reductase 2 inhibitor
0,198  0,004  Anabolic
0,214  0,027  Antifungal enhancer
0,278  0,093  CYP3A4 inhibitor
0,189  0,009  Postmenopausal disorders treatment
0,180  0,003  5-Alpha-reductase 1 inhibitor
0,191  0,014  Pregnane X receptor agonist
0,285  0,109  Antileukemic
0,192  0,019  Growth stimulant
0,190  0,019  Alcohol dehydrogenase substrate
0,215  0,047  Diabetic nephropathy treatment
0,222  0,055  Sleep disorders treatment
0,209  0,041  Diuretic
0,179  0,012  ABCA1 expression enhancer
0,259  0,093  Hypoxia-inducible factor 1 alpha inhibitor
0,216  0,053  Male reproductive disfunction treatment
0,276  0,117  Calcium channel activator
0,194  0,040  Cyclin-dependent kinase 8 inhibitor
0,179  0,026  Microtubule formation inhibitor
0,157  0,005  Na+ K+ transporting ATPase inhibitor
0,231  0,082  NOS2 expression inhibitor
0,153  0,005  Aldosterone antagonist
0,156  0,008  Premenstrual syndrome treatment
0,257  0,112  Antineoplastic (brain cancer)
0,189  0,045  NOS3 expression enhancer
0,238  0,098  Lipoprotein disorders treatment
0,225  0,087  Antineoplastic (cervical cancer)
0,173  0,035  Antieczematic
0,237  0,099  Renal disease treatment
0,192  0,055  UGT1A3 substrate
0,221  0,088  Antineoplastic (glioma)
0,232  0,100  5 Hydroxytryptamine uptake stimulant
0,197  0,066  P-glycoprotein inhibitor
0,224  0,094  Antineoplastic (sarcoma)
0,216  0,087  Angiogenesis stimulant
0,152  0,028  UGT2B1 substrate
0,218  0,095  Antidiabetic symptomatic
0,175  0,053  Amylase inhibitor
0,177  0,057  Neuropathy treatment
0,142  0,024  Acetylcholine M3 receptor agonist
0,119  0,001  Hedgehog signaling activator
0,122  0,007  Progesterone antagonist
0,163  0,049  Neurotrophic factor
0,128  0,014  Bile acid receptor antagonist
0,118  0,004  Premature ejaculation treatment
0,212  0,099  Antipyretic
0,188  0,078  Platelet adhesion inhibitor
0,236  0,127  Immunomodulator
0,144  0,036  Choleretic
0,113  0,007  Estrogen receptor alpha agonist
0,120  0,014  Estrogen agonist
0,226  0,120  Antipsoriatic
0,108  0,004  Lipocortins synthesis agonist
0,134  0,033  Estrogen antagonist
0,171  0,072  Antipruritic
0,195  0,097  Antineoplastic (lymphoma)
0,124  0,027  SULT1E1 substrate
0,143  0,048  Antiprotozoal (Amoeba)
0,094  0,003  Glucose-6-phosphate dehydrogenase inhibitor
0,144  0,053  Antihemorrhagic
0,168  0,078  Phobic disorders treatment
0,211  0,122  Cardioprotectant
0,130  0,041  AMP-activated protein kinase stimulant
0,098  0,011  Hypercalcemia treatment
0,182  0,096  Neurotrophic factor enhancer
0,142  0,056  Retinoprotector
0,157  0,072  Melanin inhibitor
0,176  0,092  Growth factor agonist
0,117  0,033  Actinic keratosis treatment
0,217  0,134  Antifungal
0,099  0,019  Anticholelithogenic
0,093  0,013  SULT2A1 substrate
0,089  0,009  Postcoital contraceptive
0,137  0,061  Liver cirrhosis treatment
0,147  0,071  Antidiabetic (type 1)
0,081  0,006  Glucocorticoid antagonist
0,155  0,081  Interleukin 6 antagonist
0,087  0,013  Estrogen receptor beta agonist
0,170  0,103  Antineoplastic (glioblastoma multiforme)
0,109  0,042  Antineoplastic antibiotic
0,075  0,008  Liver X receptor alpha agonist
0,119  0,052  Neutropenia treatment
0,079  0,014  Acetylcholine M2 receptor agonist
0,117  0,053  Acetylcholine release stimulant
0,126  0,061  Acetylcholine muscarinic antagonist
0,073  0,011  Pregnane X receptor antagonist
0,073  0,012  Liver X receptor agonist
0,212  0,152  Caspase 3 stimulant
0,071  0,014  Mineralocorticoid receptor antagonist
0,098  0,041  Transcription factor NF kappa B stimulant
0,107  0,051  Estrogen receptor beta antagonist
0,184  0,128  Antioxidant
0,059  0,006  Estrone sulfatase inhibitor
0,087  0,036  CDC25A inhibitor
0,076  0,025  Andropause treatment
0,152  0,103  Phospholipase C inhibitor
0,199  0,151  Antineoplastic (multiple myeloma)
0,178  0,131  Myocardial infarction treatment
0,065  0,018  Anesthetic inhalation
0,050  0,005  Progesterone agonist
0,056  0,011  Hypogonadism treatment
0,105  0,061  Toll-Like receptor 4 antagonist
0,151  0,108  Antihelmintic
0,174  0,131  Antineoplastic (renal cancer)
0,166  0,125  VEGF expression inhibitor
0,045  0,005  Glucocorticoid agonist
0,097  0,058  Prolactin inhibitor
0,042  0,004  Corticosteroid-like
0,074  0,036  Hyperparathyroidism treatment
0,162  0,125  Hypolipemic
0,125  0,088  Lipid peroxidase inhibitor
0,050  0,015  Farnesoid X receptor agonist
0,073  0,038  Female sexual dysfunction treatment
0,052  0,019  Parathyroid hormone antagonist
0,112  0,079  Antiviral (Hepatitis B)
0,065  0,034  Heme oxygenase stimulant
0,137  0,107  Liver fibrosis treatment
0,185  0,156  Flavin-containing monooxygenase substrate
0,155  0,127  Antiparasitic
0,130  0,103  Sigma receptor agonist
0,041  0,015  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,049  0,025  Opioid kappa receptor agonist
0,036  0,013  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,065  0,043  5 Hydroxytryptamine uptake inhibitor
0,040  0,020  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,028  0,008  Vitamin D receptor antagonist
0,170  0,152  5 Hydroxytryptamine release stimulant
0,048  0,030  Microtubule stabilization
0,148  0,131  Antirickettsial
0,079  0,063  Antiprotozoal activity enhancer
0,041  0,026  Cholesterol absorption inhibitor
0,018  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,140  0,126  Antiarrhythmic
0,036  0,022  Antihyperaldosteronism
0,079  0,070  Estrogen-related receptor beta agonist
0,075  0,066  Opioid kappa receptor antagonist
0,030  0,021  Acetylcholine M4 receptor agonist
0,157  0,149  Tumour necrosis factor alpha release inhibitor
0,058  0,051  Antimycoplasmal
0,018  0,011  Ileal bile acid transport inhibitor
0,120  0,114  Eye irritation, high
0,081  0,075  Tocolytic
0,038  0,033  Estradiol 17 beta-dehydrogenase inhibitor
0,204  0,198  Cognition disorders treatment
0,008  0,003  Transcortin receptor antagonist
0,216  0,212  Antibacterial
0,138  0,134  Antiviral (Hepatitis)
0,070  0,067  Estrogen receptor alpha antagonist
0,091  0,088  Protein-tyrosine phosphatase 1B inhibitor
0,050  0,048  Dopamine uptake inhibitor
0,140  0,140  EphB2 antagonist
0,210  0,210  Atherosclerosis treatment

